Jeffrey M Rybak

Jeffrey M Rybak

University of Tennessee Health Science Center Memphis - Memphis / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 1639242
Universität Konstanz
person_outline Jeffrey M Rybak's MOST POPULAR ARTICLES
1-) Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species Frontiers in microbiology 7, 2173, 2017
2-) Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris Antimicrobial agents and chemotherapy 63 (4), 10.1128/aac. 00057-19, 2019
3-) Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris MBio 11 (3), 10.1128/mbio. 00365-20, 2020
4-) Oritavancin: a new lipoglycopeptide antibiotic in the treatment of Gram-positive infections Infectious diseases and therapy 5, 1-15, 2016
5-) Isavuconazole: pharmacology, pharmacodynamics, and current clinical experience with a new triazole antifungal agentJM Rybak, KR Marx, AT Nishimoto, PD RogersPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (11 …, 20151122015